The shingles vaccine may offer a protective effect against developing dementia, as well as “therapeutic potential” for those ...

Routine vaccinations offered to adults may help protect against dementia, recent research has shown.

A second dose conferred an additional 67.9% effectiveness against any herpes zoster outcome. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are effective in older adults, including ...

The shingles vaccine is intended to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, also known as herpes zoster, but a new study suggests that it could have ...

European Commission approves GSK’s recombinant zoster vaccine, Shingrix in prefilled syringe: London, UK Thursday, January 8, 2026, 09:00 Hrs [IST] GSK plc announced the Europea ...

People with dementia who were vaccinated against herpes zoster, or shingles, experienced fewer deaths than those who were unvaccinated, according to findings presented at the Clinical Trials on ...

Chickenpox is a highly contagious disease caused by the varicella zoster virus (VZV). The virus is transmitted through direct ...

Shingrix, a recombinant zoster vaccine, combines glycoprotein E antigen with an adjuvant system called AS01B. It has been ...

Participants were Medicare beneficiaries aged 65 years or older with continuous Part D coverage, with no prior RZV vaccination. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are ...